| Literature DB >> 23977310 |
Preuttiporn Supaphon1, Souwalak Phongpaichit, Vatcharin Rukachaisirikul, Jariya Sakayaroj.
Abstract
Endophytic fungi from three commonly found seagrasses in southern Thailand were explored for their ability to produce antimicrobial metabolites. One hundred and sixty endophytic fungi derived from Cymodoceaserrulata (Family Cymodoceaceae), Halophilaovalis and Thalassiahemprichii (Family Hydrocharitaceae) were screened for production of antimicrobial compounds by a colorimetric broth microdilution test against ten human pathogenic microorganisms including Staphylococcus aureus ATCC 25923, a clinical isolate of methicillin-resistant S. aureus, Escherichia coli ATCC 25923, Pseudomonas aeruginosa ATCC 27853, Candida albicans ATCC 90028 and NCPF 3153, Cryptococcus neoformans ATCC 90112 and ATCC 90113 and clinical isolates of Microsporumgypseum and Penicilliummarneffei. Sixty-nine percent of the isolates exhibited antimicrobial activity against at least one test strain. Antifungal activity was more pronounced than antibacterial activity. Among the active fungi, seven isolates including Hypocreales sp. PSU-ES26 from C. serrulata, Trichoderma spp. PSU-ES8 and PSU-ES38 from H. ovalis, and Penicillium sp. PSU-ES43, Fusarium sp. PSU-ES73, Stephanonectria sp. PSU-ES172 and an unidentified endophyte PSU-ES190 from T. hemprichii exhibited strong antimicrobial activity against human pathogens with minimum inhibitory concentrations (MIC) of less than 10 µg/ml. The inhibitory extracts at concentrations of 4 times their MIC destroyed the targeted cells as observed by scanning electron microscopy. These results showed the antimicrobial potential of extracts from endophytic fungi from seagrasses.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23977310 PMCID: PMC3745589 DOI: 10.1371/journal.pone.0072520
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Number of active isolates and active extracts from endophytic fungi from three seagrass species.
|
|
|
| Total | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| No. of active isolates/ | 9/12 | 53/69 | 48/79 | 110/160 | ||
| Total no. of isolates tested (%) | (75.0) | (76.8) | (60.8) | (68.8) | ||
| No. of active extracts/ | 19/34 | 94/199 | 96/224 | 209/457 | ||
| Total no. of extracts tested (%) | (55.9) | (47.2) | (42.9) | (45.7) | ||
Figure 1Antimicrobial activity of endophytic fungal crude extracts against each test microorganism.
SA, ATCC 25923; MRSA, methicillin-resistant ; EC, ATCC 25922; PA, ATCC 27853; CA1, ATCC 90028; CA2, NCPF 3153; CN1, ATCC 90112 (flucytosine-sensitive); CN2, ATCC 90113 (flucytosine-resistant); MG, clinical isolate; PM, clinical isolate.
Distribution of the antimicrobial spectrum of inhibitory endophytic fungal extracts.
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| 14.3 | ←--------------→ | |||||||
| 19.1 | ←--------→ | |||||||
| 21.5 | ←--------------------------→ | |||||||
| 16.8 | ←------------------------------------------------------------→ | |||||||
| 14.4 | ←-------------------------------------------------→ | |||||||
| 1.0 | ←-------------→ | ←--------------------------→ | ||||||
| 12.9 | ←-----------------------------------------------------------------------------------------------------→ | |||||||
The endophytic fungal isolates from three species of seagrasses with strong antimicrobial activity.
|
|
a)
|
|
b)
| |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
c)
|
|
|
|
|
|
| ||||||||||||
|
| ||||||||||||||||||
| PSU-ES26CH ( | JN116602 |
|
| 16/>200 |
|
| ||||||||||||
|
| ||||||||||||||||||
| PSU-ES8CE ( | 64/>200 | 128/>200 |
| |||||||||||||||
| PSU-ES38CE ( | 64/>200 |
| ||||||||||||||||
|
| ||||||||||||||||||
| PSU-ES43CH ( | JN116612 |
| 32/64 | |||||||||||||||
| PSU-ES73CE ( | JQ733502 |
|
|
|
| |||||||||||||
| PSU-ES172BE ( | JN116689 |
| ||||||||||||||||
| PSU-ES172CE ( | JN116689 |
| ||||||||||||||||
| PSU-ES190CH (mycelia sterilia) |
| 32/64 | ||||||||||||||||
| Antibiotic drugs | ||||||||||||||||||
| Vancomycin | 0.5/1 | 1/2 | ||||||||||||||||
| Amphotericin B | 0.125/0.25 | 0.125/0.5 | 0.125/1 | 0.25/2 | ||||||||||||||
| Miconazole | 1/32 | |||||||||||||||||
a)CH, hexane extract from fungal cell; BE, ethyl acetate extract from culture broth; CE, ethyl acetate extract from fungal cell
b)MIC, minimum inhibitory concentration; MBC minimum bactericidal concentration; MFC, minimum fungicidal concentration
c)SA, ATCC 25923; CA1, ATCC 90028; CA2, NCPF 3153; CN1, ATCC 90112 (flucytosine-sensitive); CN2, ATCC 90113 (flucytosine-resistant); MG, clinical isolate; PM, clinical isolate
d)Identified by morphological characteristics
Figure 2Scanning electron micrographs of test microorganisms with strongly active crude extracts.
ATCC 90112 (A–E), ATCC 90113 (F), NCPF 3153 (G–I) and a clinical isolate of (K–L) after incubation with 10% DMSO (A, G and J), amphotericin B (B and H), miconazole (K), hexane extract from the mycelia of sp. PSU-ES43 (C), hexane extract from the mycelia of PSU-ES190 (D), ethyl acetate extract from the mycelia of PSU-ES73 (E and F), ethyl acetate extract from the mycelia of PSU-ES38 (I), and hexane extract from the mycelia of Hypocreales sp. PSU-ES26 (L) for 16 h at 4 times their MIC values.
Figure 3Phylogenetic tree based on ITS1-5.8S-ITS2 sequences of strongly active endophytic fungi.
The number of each branch point represents percentage bootstrap support from Maximum Parsimony (MP BS) and Neighbour Joining (NJ BS) with 100 replications shown on the branch. MP BS values ≥50% are shown before the slash; NJ BS values ≥50% are shown after the slash. Length; 37 steps; consistency index (CI); 0.8108; retention index (RI); 0.9391; homoplasy index (HI); 0.1892; rescaled consistency index (RC); 0.7615.